Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma
Joachim Merters, Ángela Lamarca
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 652-657
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
Lavinia Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 13
Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism
Yi Duan, Mengqiong Deng, Bin Liu, et al.
Biomaterials (2024) Vol. 309, pp. 122609-122609
Closed Access | Times Cited: 4
Necroptosis‐Mediated Synergistic Photodynamic and Glutamine‐Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma
Zheng Qichang, Tianhao Zou, Weimin Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 4
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, María U. Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring
Jing Yu, Q. Liu, Shuang-Yan Lu, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial
Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, et al.
Cost Effectiveness and Resource Allocation (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
Changyong Guo, Fei Gao, Guoyuan Wu, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
Yue Hu, Xiongying Jiang, Xi Cai, et al.
Journal of Gastrointestinal Oncology (2025) Vol. 16, Iss. 1, pp. 209-225
Open Access
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma
Yu Huang, Yulu Ye, Tingzhuang Yi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Recent Updates on Local Ablative Therapy Combined with Chemotherapy for Extrahepatic Cholangiocarcinoma: Photodynamic Therapy and Radiofrequency Ablation
Tadahisa Inoue, Masashi Yoneda
Current Oncology (2023) Vol. 30, Iss. 2, pp. 2159-2168
Open Access | Times Cited: 8
EUS-guided FNA and biopsy for cytohistologic diagnosis of gallbladder cancer: a multicenter retrospective study
Huapyong Kang, So Jeong Kim, Min Young, et al.
Gastrointestinal Endoscopy (2024) Vol. 100, Iss. 2, pp. 231-239.e2
Closed Access | Times Cited: 2
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date
Michael H. Storandt, Zhaohui Jin, Amit Mahipal
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 383-394
Open Access | Times Cited: 2
Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma
Natalie Bath, Timothy M. Pawlik
Chinese Clinical Oncology (2023) Vol. 12, Iss. 1, pp. 5-5
Open Access | Times Cited: 6
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
Zhitao Dong, Chengjun Sui, Jiongjiong Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Case report: From palliative to potentially curative – the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma
Eugene Kwong Fei Leong, Nigel Chun Hian Tan, Ning Qi Pang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy
Fang Wang, Chang Jiang, Wenzhuo He, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 541-557
Open Access | Times Cited: 1
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression
Antonio Cigliano, Alastair J. Strain, Massimiliano Cadamuro
Hepatoma Research (2023) Vol. 9, Iss. 14, pp. 14-14
Open Access | Times Cited: 3
The role of durvalumab in the treatment of biliary tract tumors
Е. V. Ledin, V. I. Stolyarov
Meditsinskiy sovet = Medical Council (2024), Iss. 22, pp. 172-180
Open Access
Prognostic nomogram for cholangiocarcinoma after immunotherapy
Chao Chen, Zhan Shi, Xiaoyuan Chu, et al.
Research Square (Research Square) (2024)
Open Access
Targeted therapies in biliary tract cancer—when precision becomes imprecise
Colm J. O’Rourke, Jakob Vasehus Schou, Jesper B. Andersen, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100085-100085
Open Access
The co-location of MARCO+ tumor-associated macrophages and CTSE+ tumor cells determined the poor prognosis in intrahepatic cholangiocarcinoma
Guangyu Fan, Changcheng Tao, Lin Li, et al.
Hepatology (2024)
Closed Access
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809
Belkacem Acidi, Hop S. Tran Cao
Annals of Surgical Oncology (2024) Vol. 31, Iss. 8, pp. 4837-4838
Closed Access
Effect of lidocaine pumped through hepatic artery to relieve pain of hepatic artery infusion chemotherapy
Renjie Zhang, Yiling Liao, Xiao-Ya Yang, et al.
Frontiers in Surgery (2024) Vol. 11
Open Access
Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)
Xi-lin Qu, Qian Wang, Fengfeng Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A review of biodegradable biliary stents made of magnesium metals: Current progress and future trends
Ling Liu, T. Liu, Kelvin K. Ng
Journal of Magnesium and Alloys (2024)
Open Access
Page 1 - Next Page

Scroll to top